Fintan Keegan is EVP & Technical Operations at Jazz Pharmaceuticals plc (JAZZ). They have made 2 open-market trades across 1 company since 2013, most recently 2014-07-08.
CIK 0001555411
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 31,750 | $6.7M |
Shares reported on the most recent Form 4, priced at the 2014-07-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL · 10b5-1 | 2014-07-08 | 2014-07-10 | $155.00 | $309K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL · 10b5-1 | 2014-06-17 | 2014-06-19 | $150.00 | $563K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL · 10b5-1 | 2014-06-09 | 2014-06-11 | $146.24 | $110K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL · 10b5-1 | 2014-05-08 | 2014-05-12 | $136.03 | $102K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL · 10b5-1 | 2014-04-08 | 2014-04-10 | $130.00 | $98K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2014-03-04 | 2014-03-06 | $159.90 | $742K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2013-03-07 | 2013-08-14 | $75.59 | $882K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.